Physician profile
Lucas J Eiseler
NPI 1720748700
$1,660.76
in general payments reported to CMS, 2019-2025
17 companies · $687 in 2025
The $687 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.56 · 2024: $957 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051 · Travel and Lodging: $601 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,050.68 |
| Travel and Lodging | $601.08 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $886.61 | 2024-2025 | Linq II, Micra, Cobalt Dr Mri Surescan |
| Pfizer INC. | $235.29 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.43 | 2024-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $74.38 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.10 | 2024-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $47.23 | 2025 | Camzyos |
| Amgen INC. | $37.79 | 2025 | Repatha |
| Impulse Dynamics (USA) INC. | $34.51 | 2024-2025 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $30.97 | 2024-2025 | Wainua, Brilinta |
| Alnylam Pharmaceuticals INC. | $28.69 | 2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $26.20 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $21.43 | 2024 | |
| Scpharmaceuticals INC. | $20.00 | 2025 | |
| Kestra Medical Technology Services, INC. | $18.43 | 2024 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $17.56 | 2023 | Opsumit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17.12 | 2024 | Xarelto |
| Endo USA, INC. | $15.02 | 2025 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucas Eiseler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.